OTCMKTS:ERBA - ERBA Diagnostics Stock Price, News, & Analysis

ERBA Diagnostics, Inc., through its subsidiaries, develops, manufactures, and markets diagnostic test kits or assays, and automated systems that are used to aid in the detection of disease markers primarily in the areas of autoimmune, infectious diseases, clinical chemistry, hematology, and diabetes testing. It manufactures scientific and laboratory instruments, such as Mago 4, Mago 4S, and Mago Plus systems, which perform tests in an automated mode; sells other diagnostic products manufactured by third parties in Italy; and develops, manufactures, and markets raw materials, such as antigens that are used in the production of diagnostic kits. The company also develops, manufactures, and markets autoimmune reagents and research products for use by research laboratories and commercial diagnostic manufacturers. In addition, the company provides instruments for blood cell counting and blood analysis; supplies reagents and other consumable materials; sells diabetic testing products, including the DS5 instrument, dispenser, and associated reagent kits, which measure long-term glucose control in diabetic patients; and offers equipment for use in the field of human and veterinary hematology. Further, it manufactures and sells liquid stable, diagnostics chemistry reagents used for in vitro diagnostics testing. The company markets its products through its sales force to hospitals, reference laboratories, clinical laboratories, and research laboratories, as well as to other commercial companies that manufacture diagnostic products in the United States; and through sales representatives and independent agents in Italy, as well as through independent distributors internationally. The company was founded in 1980 and is headquartered in Miami Lakes, Florida. ERBA Diagnostics, Inc. is a subsidiary of ERBA Diagnostics Mannheim GmbH.

ERBA Diagnostics (OTCMKTS:ERBA) Frequently Asked Questions

What is ERBA Diagnostics' stock symbol?

ERBA Diagnostics trades on the OTCMKTS under the ticker symbol "ERBA."

How were ERBA Diagnostics' earnings last quarter?

ERBA Diagnostics Inc (OTCMKTS:ERBA) announced its earnings results on Wednesday, August, 5th. The company reported ($0.01) earnings per share for the quarter, topping analysts' consensus estimates of ($0.02) by $0.01. The business earned $5.90 million during the quarter, compared to the consensus estimate of $5.16 million. View ERBA Diagnostics' Earnings History.

Who are some of ERBA Diagnostics' key competitors?

Some companies that are related to ERBA Diagnostics include VIVUS (VVUS), AzurRx BioPharma (AZRX), GTX (GTXI), Evoke Pharma (EVOK), Acasti Pharma (ACST), Heat Biologics (HTBX), Addex Therapeutics (ADDXF), Avenue Therapeutics (ATXI), Acerus Pharmaceuticals (TRLPF), KemPharm (KMPH), Novus Therapeutics (NVUS), Eyenovia (EYEN), Advaxis (ADXS), Aileron Therapeutics (ALRN) and ProPhase Labs (PRPH).

Who are ERBA Diagnostics' key executives?

ERBA Diagnostics' management team includes the folowing people:

• Mr. Suresh Vazirani, Exec. Chairman & MD (Age 68)
• Mr. David Barka, Interim Chief Exec. Officer (Age 37)
• Dr. Chandra Krishnan, Sr. VP of Global Sales, Marketing and Bus. Devel.
• Mr. Ray Earl, VP of Sales - Diamedix Corp

How do I buy shares of ERBA Diagnostics?

Shares of ERBA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is ERBA Diagnostics' stock price today?

One share of ERBA stock can currently be purchased for approximately $0.25.

How big of a company is ERBA Diagnostics?

ERBA Diagnostics has a market capitalization of $11.70 million.

What is ERBA Diagnostics' official website?

The official website for ERBA Diagnostics is http://www.erbadiagnostics.com.

How can I contact ERBA Diagnostics?

ERBA Diagnostics' mailing address is 14100 Nw 57th Court, Miami Lakes FL, 33014. The company can be reached via phone at 305-324-2300 or via email at [email protected]